tetrasodium,(1Z)-5-amino-1-[[4-[4-[(2Z)-2-(5-amino-4-oxo-2,7-disulfonatonaphthalen-1-ylidene)hydrazinyl]-3-chlorophenyl]-2-chlorophenyl]hydrazinylidene]-4-oxonaphthalene-2,7-disulfonate

MOLECULAR FORMULA :

C32-H18-Cl2-N6-O14-S4.4Na

MOLECULAR WEIGHT :

1001.66

WISWESSER LINE NOTATION :

L66J BQ DSWO HSWO JZ CNUNR CG DR BG DNUN- CL66J BQ DSWO HSWO JZ &-NA- 4

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :

TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :

Subcutaneous

DOSE :

50 mg/kg

SEX/DURATION :

female 8 day(s) after conception

TOXIC EFFECTS :

Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - other developmental abnormalities

REFERENCE :

BIJOAK Biochemical Journal. (Biochemical Soc. Book Depot, POB 32, Commerce Way, Colchester, Essex CO2 8HP, UK) V.1- 1906- Volume(issue)/page/year: 91,14P,1964 *** REVIEWS *** TOXICOLOGY REVIEW ADTEAS Advances in Teratology. (New York, NY) V.1-5, 1966-72. Discontinued. Volume(issue)/page/year: 1,131,1966